Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002;62(17):2413-20.
doi: 10.2165/00003495-200262170-00001.

Influenza vaccinations: who needs them and when?

Eelko Hak  1 , Arno W Hoes, Theo J M Verheij
Affiliations
Review

Influenza vaccinations: who needs them and when?

Eelko Hak et al. Drugs. 2002.

Abstract

Influenza vaccination programmes should aim at reducing the burden from influenza among those who need it most. The primary aim of this literature review is to identify who should receive priority in influenza vaccination programmes. Risk factors for severe post-influenza complications include immune-related factors, such as ageing or the presence of immune-suppression, respiratory tract disease, proneness to exacerbation of concomitant high-risk disease, potential adverse effects associated with long-term drug use or residence in closed communities with high transmission rate. When given annually in autumn, inactivated trivalent influenza vaccines can reduce severe complications from influenza among persons aged 65 years or older by 30-60%. Among children aged less than 7 years, notably those with asthma, the occurrence of otitis media or acute respiratory disease is reduced by 20-75% with vaccination. In addition, vaccination of residents of long-term care facilities and their personnel leads to a 42% reduction in mortality among patients. However, uncertainty remains about whether influenza vaccination can reduce complications from influenza among the large group of older children and persons of working-age with high-risk disease. To further increase the impact of prevention strategies, the development and application of clinical prediction rules to estimate absolute risks of post-influenza complications should be studied in relation to optimal vaccine delivery strategies. Furthermore, adequately powered studies should be conducted to demonstrate possible effectiveness of vaccination in reducing post-influenza complications among older children and working-age adults.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Circulation. 2000 Dec 19;102(25):3039-45 - PubMed
    1. N Engl J Med. 2000 Dec 14;343(24):1778-87 - PubMed
    1. BMJ. 1993 May 29;306(6890):1452-4 - PubMed
    1. Lancet. 1998 Dec 12;352(9144):1877-81 - PubMed
    1. Pharmacoeconomics. 1999;16 Suppl 1:63-71 - PubMed

Publication types

Substances

LinkOut - more resources